The association of dyslipidermia and inflammatory markers with decreased renal function has been reported in several large epidemiologic studies. In this issue, Lin et al examine these associations among middle-aged and older type 2 diabics, a population at high risk for chronic kidney disease. Their findings support a role for these factors in the pathogenesis of progressive renal disease
Background: Chronic Kidney Disease (CKD) is one of the most severe diseases worldwide. In patients a...
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and prog...
Patients with chronic kidney disease (CKD) represent an important segment of the population (7–10%) ...
The association of dyslipidermia and inflammatory markers with decreased renal function has been rep...
Dyslipidemia and the progression of renal disease in chronic renal failure patients Dyslipidemia is ...
Patients with chronic kidney disease (CKD), irrespective of initial etiology, have a risk of cardiov...
In an analysis based on the Mild to Moderate Kidney Disease (MMKD) study, adiponectin, a pleiotropic...
“New” cardiovascular risk factors in patients with chronic kidney disease: Role of folic acid treatm...
Accumulating evidence supports that components of the metabolic syndrome coexist with both albuminur...
Patients with chronic kidney disease (CKD) have a risk of cardiovascular morbidity and mortality th...
Nephropathic subjects show an increased tendency to develop cardiovascular diseases, mainly as the c...
Chronic kidney disease, especially in the setting of proteinuria, is characterized by hyperlipidemia...
End-stage renal disease (ESRD) is characterized by an exceptional mortality rate, much of which is t...
Recent advances in statins and the kidneyBackgroundExperimental and clinical studies have suggested ...
Obesity is a chronic disease, whose incidence is alarmingly growing. It is associated with metabolic...
Background: Chronic Kidney Disease (CKD) is one of the most severe diseases worldwide. In patients a...
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and prog...
Patients with chronic kidney disease (CKD) represent an important segment of the population (7–10%) ...
The association of dyslipidermia and inflammatory markers with decreased renal function has been rep...
Dyslipidemia and the progression of renal disease in chronic renal failure patients Dyslipidemia is ...
Patients with chronic kidney disease (CKD), irrespective of initial etiology, have a risk of cardiov...
In an analysis based on the Mild to Moderate Kidney Disease (MMKD) study, adiponectin, a pleiotropic...
“New” cardiovascular risk factors in patients with chronic kidney disease: Role of folic acid treatm...
Accumulating evidence supports that components of the metabolic syndrome coexist with both albuminur...
Patients with chronic kidney disease (CKD) have a risk of cardiovascular morbidity and mortality th...
Nephropathic subjects show an increased tendency to develop cardiovascular diseases, mainly as the c...
Chronic kidney disease, especially in the setting of proteinuria, is characterized by hyperlipidemia...
End-stage renal disease (ESRD) is characterized by an exceptional mortality rate, much of which is t...
Recent advances in statins and the kidneyBackgroundExperimental and clinical studies have suggested ...
Obesity is a chronic disease, whose incidence is alarmingly growing. It is associated with metabolic...
Background: Chronic Kidney Disease (CKD) is one of the most severe diseases worldwide. In patients a...
Recent epidemiological research revealed that dyslipidemia is a risk factor for development and prog...
Patients with chronic kidney disease (CKD) represent an important segment of the population (7–10%) ...